AI assistant
Cytosorbents Corp — Director's Dealing 2014
Jul 2, 2014
34501_dirs_2014-07-02_f085b452-4ca4-43a1-8d81-0a403e82f008.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-06-30
Reporting Person: Kraus Al (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-30 | Common Stock | M | 50000 | $0.035 | Acquired | 1443631 | Direct |
| 2014-06-30 | Common Stock | S | 50000 | $0.236 | Disposed | 1393631 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | Stock Option | $0.035 | M | 50000 | Disposed | 2018-06-25 | Common Stock (50000) | Direct |
Footnotes
F1: Stock option exercise and open market sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $0.235 to $0.24.
F3: The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.